Dallas, TX (PRWEB) September 20, 2013 Stroke occurs when the blood supply to the brain is blocked or interrupted, either by blood clots or ruptured blood vessels, depriving the brain of oxygen and nutrients, ultimately leading to the death of brain cells. Stroke is a major cause of death, morbidity, and long-term disability. To forecast the incident and prevalent cases of stroke in the 6MM, Epidemiologists selected studies that used the WHO definition of stroke: rapidly developing clinical signs of focal disturbance of cerebral function, lasting more than 24 hours or leading to death, with no apparent cause other than that of vascular origin. This definition excludes cases of transient ischemic attacks (TIAs), which are neurological deficits lasting less than 24 hours. This report also provides the incident cases of AIS segmented by the TOAST (Trial of Org 10172 in Acute Stroke Treatment) criteria subtypes and the proportion of recurrent cases of AIS out of the total cases of AIS (total cases of AIS = incident cases of first-ever AIS + recurrent cases of AIS) in these major markets. Complete report is available @ http://www.rnrmarketresearch.com/epicast-report-acute-ischemic-stroke-epidemiology-forecast-to-2022-market-report.html. Epidemiologists forecast that the incident cases of AIS in the 6MM will increase by 20.10% … Continue reading →

THE eighth annual Our Heroes Awards was a night where celebrities and VIPs gathered to pay tribute to inspirational individuals and unsung heroes who go the extra mile to help others. The night's moving moments at the Moat House Hotel, in Festival Park, Etruria, came courtesy of the nominees. An audience of 250 people heard stories of unconditional love, daily struggles, selflessness and determination that provide lessons for us all. The whole spectrum of emotions were experienced, from sadness to sheer joy at seeing such deserving people receive recognition. During the past eight years, The Our Heroes Awards, sponsored by The Aspire Group, has seen The Sentinel publish more than 1,000 heartwarming stories and prizes have been given out to more than 200 winners. Following a black-tie dinner, 29 awards were handed out during an Oscars-style ceremony hosted by Aspire Group chief executive Sinad Butters and Sentinel columnist and deputy editor Martin Tideswell. The Only Way Is Stoke (TOWIS) Print voucher EYEBROW WAX FOR ONLY 3 AND EYEBROW TINTING IS ONLY 5. BOOK NOW AND SET OFF YOUR GORGEOUS EYES AT THE ONLY WAY IS STOKE XX Contact: 01782 917864 Valid until: Tuesday, December 31 2013 The first award of … Continue reading →

Irvine, CA (PRWEB) September 20, 2013 Proove Biosciences, Inc., the leading personalized pain medicine laboratory, is excited to announce that they will be attending and exhibiting at the California Society of Interventional Pain Physicians 4th Annual Meeting this weekend at the Terranea Resort in Rancho Palos Verdes, California. The event will be held from September 20th to September 22nd. CASIPP is a growing advocacy society working for interventional pain management physicians and their staff within the state of California. The organizations mission is to promote the development and practice of safe, high quality, cost-effective interventional pain medicine techniques for the diagnosis and treatment of pain and related disorders, and ensure patient access to these interventions. We are proud to support Dr. Ray d'Amours, the President and Executive Director of CASIPP in this important conference, explains Proove CEO and founder, Brian Meshkin. Proove is a research-driven company committed to realizing the potential of personalized pain medicine. We are proud to stand with Dr. dAmours and his colleagues at the forefront of pain medicine genetics. We continue to be the only company to present clinical research on the genetics of pain medicine at scientific meetings throughout the year including, PAINWeek, the American … Continue reading →

SUNRISE, FL--(Marketwired - Sep 20, 2013) - Bioheart (OTCQB: BHRT), a leader in developing stem cell therapies to treat cardiovascular diseases, has expanded its team by adding three key strategic positions with regulatory, finance and administrative expertise. "This experienced and talented team will assist Bioheart in its transformation to a late stage clinical biotechnology company," said Mike Tomas, CEO of Bioheart. Joining as Senior Compliance Officer of Bioheart, Dr. Colleen Robb ensures third-party objectivity in all internal processes, and works with management on external negotiations and the development of Bioheart's FCPA protocols as the company expands international efforts. With more than 14 years of experience in the non-profit sector, Dr. Robb is recognized internationally as a prominent researcher in the area of social entrepreneurship and strategy, specifically examining how social ventures can maintain advantage in the marketplace. Prior to joining Bioheart, she was an Assistant Professor of undergraduate and graduate programs at Keller Graduate School of Management at DeVry University. Dr. Robb received her doctoral degree from bo Akademi University in Turku, Finland and her master's degree in business administration from Florida International University. Finance and Operations Manager Gisela Freeman is a tenured legal and finance operations executive with more … Continue reading →